Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Historically, providers would need to log into separate portals or support different workflows for each CGM manufacturer to review the data from their patients. Additionally, it was cumbersome to ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million.

Do you struggle to fall asleep at night, or regularly wake up feeling tired? If so, you might find answers by learning about ...

Already granted breakthrough device designation from the FDA, the system will take the form of a small patch-like device similar to Abbott’s FreeStyle Libre 3 device.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

More than 800 people will be employed at the plant which will be the biggest production centre worldwide for the group’s ...

Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...